Optohive develops wearable brain imaging systems based on functional near-infrared spectroscopy (fNIRS) designed for real-time neural monitoring. The company’s platform, including the HiveOne device paired with AI-driven software, enables measurement of cortical brain activity in a compact, wearable form factor. Its approach focuses on delivering high-precision neural data without the constraints of traditional imaging systems. Optohive positions its technology within clinical and research neuroimaging contexts.

The technology measures changes in oxygenated and deoxygenated hemoglobin to infer neural activity across targeted cortical regions. AI-based analytics are applied to process fNIRS signals in real time, supporting noise reduction, feature extraction, and interpretation. This enables continuous monitoring of brain function during tasks or clinical assessment. The system emphasizes accuracy, repeatability, and integration into existing research and clinical workflows.

Optohive targets applications in neuroscience research, clinical monitoring, and applied brain health assessment. The platform is intended for use by researchers and clinicians rather than consumer wellness applications. Its positioning reflects growing demand for wearable neuroimaging tools that combine precision measurement with real-time analytics.